| |
|
Sertoli cell tumour
|
Borderline endometrioid tumour
|
Sertoliform endometrioid carcinoma
|
Well-differentiated endometrioid carcinoma
|
Carcinoid tumour
|
Diagnostic value
|
|
|
number of cases
|
40
|
38
|
13
|
27
|
42
|
|
|
CK7
|
13%(staining frequently focal)
|
100%(staining frequently diffuse)
|
85%(staining frequently diffuse)
|
100%(staining frequently diffuse)
|
24%(staining frequently focal)
|
positivity favours endometrioid carcinoma
|
|
ER
|
8%(staining focal)
|
87%(staining frequently diffuse)
|
85%(staining frequently diffuse)
|
89%(staining frequently diffuse)
|
2%(staining focal)
|
positivity favours endometrioid carcinoma
|
|
PR
|
13%(staining focal)
|
84%(staining frequently diffuse)
|
77%(staining frequently diffuse)
|
93%(staining frequently diffuse)
|
2%(staining focal)
|
positivity favours endometrioid carcinoma
|
|
pan CK
|
65%(staining variable)
|
100%(staining frequently diffuse)
|
100%(staining frequently diffuse)
|
100%(staining frequently diffuse)
|
98%(staining frequently diffuse)
|
not useful
|
|
CK8/18
|
43%(staining variable)
|
100%(staining frequently diffuse)
|
93%(staining frequently diffuse)
|
96%(staining frequently diffuse)
|
74%(staining frequently diffuse)
|
not useful
|
|
EMA
|
0%
|
100%(staining frequently diffuse)
|
100%(staining frequently diffuse)
|
100%(staining frequently diffuse)
|
12%(staining focal)
|
positivity favours endometrioid carcinoma
|
|
CD10
|
25%(staining variable)
|
39%(staining variable)
|
31%(staining variable)
|
37%(staining variable)
|
9%(staining variable)
|
not useful
|
|
Inhibin
|
98%(staining frequently diffuse)
|
0%
|
0%
|
4%(staining focal)
|
2%(staining focal)
|
positivity favors Sertoli cell tumour
|
|
Calretinin
|
60%(staining frequently diffuse)
|
11%(staining focal)
|
0%
|
18%(staining focal)
|
0%
|
positivity favors Sertoli cell tumour
|
|
CD99
|
68%(staining variable)
|
16%(staining variable)
|
23%(staining variable)
|
33%(staining variable)
|
40%(staining variable)
|
not useful
|
|
CD56
|
48%(staining focal to variable)
|
16%(staining focal to variable)
|
16%(staining focal to variable)
|
30%(staining focal to variable)
|
57%(staining diffuse)
|
not useful
|
|
Synaptophysin
|
35%(staining focal)
|
8%(staining focal)
|
8%(staining focal)
|
22%(staining focal)
|
98%(staining frequently diffuse)
|
positivity favours carcinoid tumour
|
|
Chromogranin
|
13%(staining focal)
|
3%(staining focal)
|
15%(staining focal)
|
11%(staining focal)
|
100%(staining frequently diffuse)
|
positivity favours carcinoid tumour
|
| |
|
|
|
|
|
|